News and Articles

Local News

Alnylam’s Lumasiran Sees Positive Results for Ultra-Rare Kidney Disease

BioSpace | December 19, 2019

Cambridge, Massachusetts-based Alnylam Pharmaceuticals announced positive results from its ILLUMINATE-A Phase III trial. The study was investigating lumasiran,…

sciencecityDecember 19, 2019

Publications of the Week

Toward a Common Coordinate Framework for the Human Body

Rood, E., J., et al. | December 19, 2019

Understanding the genetic and molecular drivers of phenotypic heterogeneity across individuals is central to biology.…

sciencecityDecember 19, 2019

Featured Awards

Dana-Farber Researcher Awarded Victoria Mock New Investigator Award

Dana-Farber Cancer Institute | December 19, 2019

Robert Knoerl, PhD, RN, an instructor in medicine and nurse scientist in the Phyllis F. Cantor…

sciencecityDecember 19, 2019

Local News

Mass General Team Detects Alzheimer’s Early Using Electronic Health Records

Mass General News | December 19, 2019

A team of scientists from Massachusetts General Hospital (MGH) has developed a software-based method of…

sciencecityDecember 19, 2019

Local News

In an About Face, FDA Approves Sarepta’s 2nd Duchenne Drug

| December 18, 2019

The FDA unexpectedly reversed course Thursday, approving the second treatment developed by Sarepta Therapeutics for the rare…

sciencecityDecember 18, 2019

Local News

Screen Could Offer Better Safety Tests for New Chemicals

MIT News | December 18, 2019

It’s estimated that there are approximately 80,000 industrial chemicals currently in use, in products such…

sciencecityDecember 18, 2019

Local News

New Tool Could Help Researchers Design Better Cancer Vaccines

Broad Institute | December 18, 2019

Every cell in the human body is coated with fragments of proteins called antigens that…

sciencecityDecember 18, 2019

Uncategorized

Targeted Small-Molecule Agent Shows Early Promise against a Dangerous Infant Leukemia

Boston Children's Hospital | December 18, 2019

Leukemias involving reshuffling or rearrangement of the mixed lineage leukemia (MLL) gene, known as MLL-rearranged or MLL-r…

sciencecityDecember 18, 2019

Local News

Gene Therapy to Boost Fetal Hemoglobin Continues to Do Well in Sickle Cell Trial

Boston Children's Hospital | December 18, 2019

A pilot gene therapy treatment for sickle cell disease, restoring patients’ ability to make fetal…

sciencecityDecember 18, 2019

Local News

New Clinical Trial Hopes to Improve Long-Term Outcomes for Heart Transplant Patients

Boston Children's Hospital | December 18, 2019

The TEAMMATE (Tacrolimus/Everolimus vs. Tacrolimus/MMF in pediatric heart transplant recipients using the MATE Score) trial…

sciencecityDecember 18, 2019

Categories